Treatment of glomerulonephritis with indomethacin and heparin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009393:Nephritis / Q000150:complications / Q000188:drug therapy; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology; D011693:Purpura / Q000150:complications; D012075:Remission, Spontaneous; D013290:Streptococcal Infections / Q000150:complications
D006493:Heparin; D007213:Indomethacin